Safety and Pharmacokinetics of IGSC 20% in Subjects with Primary Immunodeficiency in an Open-label, Multicenter, Phase 3 Study
JOURNAL OF CLINICAL IMMUNOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL IMMUNOLOGY(2019)